Evidence map›Paper›PMID 29703785›Full record

ArticleG3 (Bethesda, Md.)2018

A Cloning-Free Method for CRISPR/Cas9-Mediated Genome Editing in Fission Yeast.

Xiao-Ran Zhang, Jia-Bei He, Yi-Zheng Wang, Li-Lin Du

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Optimization of the CRISPR/Cas9 system usingmicroPublication biology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Genome editing systems across yeast species.Current opinion in biotechnology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Xiao-Ran ZhangNational Institute of Biological Sciences, Beijing, China 102206.
Jia-Bei HeNational Institute of Biological Sciences, Beijing, China 102206.
Yi-Zheng WangPTN Graduate Program, School of Life Sciences, Tsinghua University, Beijing, China 100084.
Li-Lin DuNational Institute of Biological Sciences, Beijing, China 102206 dulilin@nibs.ac.cn.ORCID 0000-0002-1028-7397
National Institute of Biological Sciences, Beijing · CNChina Agricultural University · CNTsinghua University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The CRISPR/Cas9 system, which relies on RNA-guided DNA cleavage to induce site-specific DNA double-strand breaks, is a powerful tool for genome editing. This system has been successfully adapted for the fission yeast

Indexed as

Base SequenceCloning, MolecularCRISPR-Cas SystemsDNA RepairGene EditingGene Knock-In TechniquesPoint MutationSchizosaccharomycesSequence DeletionTemperatureCRISPR/Cas9fission yeastgap repairgenome editingSchizosaccharomyces pombe

Identifiers

PMID29703785
PMCPMC5982833
OpenAlexW2949863002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.